CBD Life Sciences
Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis
Dispensary
With the New York
cannabis market projected to surpass $5 billion by 2027, this
acquisition positions CBDL for exponential revenue growth and
expanded market dominance.
SCOTTSDALE, AZ -- November 19, 2024 -- InvestorsHub
NewsWire -- CBD Life Sciences Inc.
(OTC:
CBDL), a pioneering force in the CBD and cannabis industries,
is proud to announce the signing of a pivotal Letter of Intent
(LOI) to acquire an interest in a cannabis dispensary located in
New York. The dispensary, purchased from Market Wave Capital, LLC,
is expected to generate $8 million in annual revenue once
operational and marks a transformative moment in CBDL's journey
toward industry dominance. Pending financing and state regulatory
approvals, the dispensary is slated to open its doors within six
months, ushering in a new chapter of accelerated growth and
profitability.
A Game-Changing
Move in a Booming Industry
The global marijuana dispensary market
is on a meteoric rise, projected to grow at a compound annual
growth rate (CAGR) of 25.5%, with revenues anticipated to surpass
$73.6 billion by 2030. New York, a burgeoning hub for cannabis
consumption and sales, presents unparalleled opportunities for
growth, thanks to progressive legislation and a rapidly expanding
consumer base.
"This acquisition is a monumental
milestone for CBD Life Sciences and a testament to our aggressive
growth strategy," said Lisa Nelson, President and CEO
of CBDL. "The dispensary's
location in New York positions us at the epicenter of one of the
fastest-growing cannabis markets in the world. With projected
revenues of $8 million annually, this venture is set to deliver
significant value to our shareholders while opening new doors for
expansion into adjacent markets."
Why This Matters
for CBDL and Its Investors
The dispensary's strategic location in
New York provides immediate access to a cannabis market projected
to exceed $5 billion in annual sales by 2027. CBDL is seizing this
opportunity at a critical juncture in the industry's evolution,
aligning itself with the broader movement toward cannabis
legalization and normalization.
For investors, this development
underscores the company's ability to execute high-impact
initiatives while navigating a highly competitive and regulated
market. The acquisition not only bolsters CBDL's revenue potential
but also establishes a foundation for future ventures in high -
demand sectors, including recreational, medical, and hybrid
cannabis markets.
Furthermore, the dispensary is
expected to serve as a gateway for CBDL to introduce its own
product lines into a retail setting, creating cross-promotional
opportunities and fostering brand loyalty among a rapidly growing
customer base.
Revenue, Growth,
and a Vision for the Future
With potential revenues of $8 million
annually, this acquisition is a significant leap forward for CBDL's
financial profile. Beyond the immediate economic impact, this
strategic move sets the stage for:
•
Market
Diversification: The
dispensary adds a robust revenue stream, complementing CBDL's
existing portfolio of CBD products.
•
Future
Expansion: Establishing a
foothold in New York lays the groundwork for scaling operations to
other states as cannabis legalization continues to gain
momentum.
•
Enhanced
Shareholder Value: The
dispensary's profitability will drive returns for current
shareholders while making CBDL an attractive investment for new
stakeholders.
Strategic
Significance
The acquisition reflects CBDL's
forward-thinking approach to growth, as the company positions
itself at the intersection of opportunity and innovation. By
tapping into the New York cannabis market, CBDL is not just
diversifying its portfolio but also creating synergies between its
dispensary operations and its existing product lines, including
pain creams, nano CBD coffee creamers, and more.
Additionally, the dispensary aligns
with CBDL's mission to provide high-quality cannabis solutions
while embracing consumer trends and regulatory changes. This move
reinforces CBDL's standing as a company that is not only thriving
in the present but also building for the future.
A Call to
Shareholders and Future Investors
"This is only the beginning," added
Nelson. "CBDL's strategic direction is clear: growth, innovation,
and value creation. The dispensary will act as a springboard for
broader ventures, and we are just getting started in leveraging the
opportunities this industry offers."
CBDL invites shareholders and
prospective investors to join us on this journey as we solidify our
position as a leader in the cannabis and CBD industries. This
acquisition underscores our commitment to seizing high-value
opportunities and delivering long-term
value to our shareholders. More
updates to come!
About CBD Life
Sciences Inc.
CBD Life Sciences Inc. (OTC: CBDL) is
a leading innovator in the CBD and cannabis industries, with a
mission to enhance lives through premium-quality products and
groundbreaking market strategies. The company's diverse
portfolio and forward-thinking initiatives position it as a dynamic
force in one of the most exciting and fast-growing industries in
the world.
Follow our social media for the latest
updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking
Statements
Except for the historical information
contained herein, the matters discussed in this press release are
forward-looking statements. Actual results may differ materially
from those described in forward-looking statements and are subject
to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s
filings with OTC Markets, which may identify specific factors that
may cause actual results or events to differ materially from those
described in the forward-looking statements.
Safe Harbor
Statement
This release includes forward-looking
statements, which are based on certain assumptions and reflects
management's current expectations. These forward-looking statements
are subject to a number of risks and uncertainties that could cause
actual results or events to differ materially from current
expectations. Some of these factors include: general global
economic conditions; general industry and market conditions, sector
changes and growth rates; uncertainty as to whether our strategies
and business plans will yield the expected benefits; increasing
competition; availability and cost of capital; the ability to
identify and develop and achieve commercial success; the level of
expenditures necessary to maintain and improve the quality of
services; changes in the economy; changes in laws and regulations,
including codes and standards, intellectual property rights, and
tax matters; or other matters not anticipated; our ability to
secure and maintain strategic relationships and distribution
agreements. The Company disclaims any intention or obligation to
update or revise any forward-looking ability to secure and maintain
strategic relationships and distribution agreements. The Company
disclaims any intention or obligation to update or revise
any
forward-looking statements.
Contact
Information: Lisa
Nelson
CEO cbdvaultaz@gmail.com
4802091720
